Jagat Pharma & Dr Basu Group Endeavours for 250+ Crore Revenue by Fiscal Year 2027
Jagat Pharma, a trusted name in Ayurvedic wellness, is poised for remarkable growth as it targets revenue exceeding ₹250 crore by the financial year 2027. Renowned for its expertise in Ayurvedic eye care and wellness…